# Journey through tumorverse: Creating models to decode PXA mysteries

## TL;DR

This paper explores the progression of a rare brain tumor in children using a new mouse model to study immune system interactions.

## Contribution

The study introduces a novel immunocompetent mouse model for studying BRAF V600E pediatric low-grade glioma.

## Key findings

- The RCAS-BRAF V600E model recapitulates key features of human PXA tumors.
- The model enables profiling of immunological dynamics in BRAF V600E pLGG.
- It provides insights into tumor progression and immune interactions.

## Abstract

Pleomorphic xanthoastrocytoma (PXA) is a rare pediatric low-grade glioma (pLGG), of which 60%–80% exhibit the BRAF V600E mutation, that enhances the aggressiveness and progression to an eventual pediatric high-grade glioma (pHGG). Despite the aggressiveness of this mutational status, the mechanisms underlying the progression of BRAF V600E tumors remain poorly understood, primarily due to limited insights into their in vivo growth dynamics. In this issue, Rajappa and colleagues leverage a novel immunocompetent RCAS-BRAF V600E murine glioma model to profile the immunological dynamics taking place in BRAF V600E pLGG.